Patent US5981598A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5981598A Expired / Lapsed US ⏱️ 0.0 years remaining

Deprenyl compounds for treatment of glaucoma

Assignee: University of Toronto
•
Filing: 1998-07-20
•
Granted: 1999-11-09
•
Expires: 2018-07-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and kits for treament of glaucoma are disclosed. In general, the methods of the invention include administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.

Inventors

  • 👤 William G. Tatton

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 15:32
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/137; A61P; A61P27/00; A61P27/02; A61P27/06

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 29 words
A method for treating a subject for glaucoma, comprising: administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
Claim 2
Independent Claim 29 words
A method for treating a subject for glaucoma, comprising: administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma.
Claim 3
Dependent Claim 133 words
The method of claim 1, wherein the deprenyl compound is represented by the structure: ##STR12## in which R 1 is hydrogen, alkyl, alkenyl, alkynyl, aralkyl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, or aryloxycarbonyl; R 2 is hydrogen or alkyl; R 3 is a single bond, alkylene, or --(CH 2 ) n--X-- (CH 2 ) m ; in which X is O, S, or N-methyl; m is 1 or 2; and n is 0,1, or 2; R 4 is alkyl, alkenyl, alkynyl, heterocyclyl, aryl or aralkyl; and R 5 is alkylene, alkenylene, alkynylene and alkoxylene; and R 6 is C 3 -C 6 cycloalkyl or --C.tbd.CH; or R 2 and R 4 --R 3 are joined to form, together with the methine to which they are attached, a cyclic or polycyclic group; and pharmaceutically acceptable salts thereof.
Claim 4
Dependent Claim 17 words
The method of claim 2, wherein R 1 is a group that can be removed in vivo.
Claim 5
Dependent Claim 10 words
The method of claim 2, wherein R 1 is hydrogen.
Claim 6
Dependent Claim 10 words
The method of claim 2, wherein R 1 is alkyl.
Claim 7
Dependent Claim 10 words
The method of claim 5, wherein R 1 is methyl.
Claim 8
Dependent Claim 10 words
The method of claim 2, wherein R 2 is methyl.
Claim 9
Dependent Claim 10 words
The method of claim 2, wherein R 3 is methylene.
Claim 10
Dependent Claim 10 words
The method of claim 2, wherein R 4 is aryl.
Claim 11
Dependent Claim 10 words
The method of claim 2, wherein R 4 is phenyl.
Claim 12
Dependent Claim 10 words
The method of claim 2, wherein R 5 is methylene.
Claim 13
Dependent Claim 10 words
The method of claim 2, wherein R 6 is --C.tbd.CH.
Claim 14
Dependent Claim 27 words
The method of claim 2, wherein the deprenyl compound has the structure ##STR13## wherein R 1 is hydrogen, alkyl, alkenyl, alkynyl, aralkyl, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, or aryloxycarbonyl.
Claim 15
Dependent Claim 11 words
The method of claim 1, wherein the deprenyl compound is (-)-deprenyl.
Claim 16
Dependent Claim 11 words
The method of claim 1, wherein the deprenyl compound is (-)-pargyline.
Claim 17
Dependent Claim 11 words
The method of claim 1, wherein the deprenyl compound is (-)-desmethyldeprenyl.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-11-08 2003-05-10 2003-11-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-11-08 2007-05-10 2007-11-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-11-08 2011-05-10 2011-11-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag